PGHH — Procter & Gamble Hygiene and Health Care Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesConservativeMid CapNeutral

Market Cap
IN₹292.81bn
Enterprise Value
IN₹286.57bn
Revenue
IN₹42.90bn

Annual income statement for Procter & Gamble Hygiene and Health Care, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	9 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	39,009	39,179	42,057	33,744	42,904
Cost of Revenue
Gross Profit	18,844	18,726	21,534	17,662	27,253
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	31,151	31,024	32,827	25,244	31,568
Operating Profit	7,858	8,155	9,230	8,500	11,336
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	7,901	8,395	9,392	8,622	11,666
Provision for Income Taxes
Net Income After Taxes	5,758	6,781	6,750	6,366	8,565
Net Income Before Extraordinary Items
Net Income	5,758	6,781	6,750	6,366	8,565
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	5,758	6,781	6,750	6,366	8,565
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	180	211	212	195	264
Dividends per Share
Special Dividends per Share